Publicerat: 2024-06-26 13:07:03

Analyst Group Comment on ODI Pharma’s Strategic Market Entry to Switzerland

ODI Pharma announced on June 25th that the company has completed a first delivery of products to the Swiss market, a new market for ODI Pharma. The delivery will be made to the leading medical cannabis provider in Switzerland and will be facilitated through ODI Pharma’s Swiss subsidiary.

Länk till analysen

Läs mer om ODI Pharma AB